Oncopharmpod
AMPLIFY
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:25
- Mas informaciones
Informações:
Sinopsis
We take a deep look at the recently published, and guideline changing, AMPLIFY trial of fixed-duration acalabrutinib in CLL. Link: DOI: 10.1056/NEJMoa2409804
